Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...

Weight Watchers is Novo Nordisk's latest partnersip.

A large study of Novo Nordisk's Wegovy, started in 2018, finds that the anti-obesity treatment cut the chances of heart attacks, strokes, and cardiovascular deaths by 20%. The study raises questions ...

UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

GE to spend $490 million on Kentucky plant; Weight Watchers partners with Novo Nordisk to sell Wegovy; TSA warns: Waffle ...

Under the deal, cash-paying patients can access a month’s supply of Wegovy through the Danish drugmaker’s Novocare pharmacy for $299. The one-time price will also be available through Novo’s other ...

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

Days after the breakdown of the partnership with telehealth company Hims & Hers, Novo Nordisk has announced a new deal with WeightWatchers. Also in the news: UnitedHealth, EasterSealsNH, Carlsmed, and ...

STORY: Novo Nordisk is to collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy.Under the deal to ...

The partnership helps Novo capture patients who have been using compounded versions of the medicine, while allowing ...